Dr. Michael Snyder

And we would do it every three months and we do it while they're healthy.

If they got ill, like from a viral infection, things like that, we would take more samples to be able to collect more carefully to see what was going on when they first got ill.

And so we've been running this study on me now for about 15 and a half years.

and for this group of people about almost 12 1⁄2 years.

So we've been profiling this group of people.

Some have dropped off by now because it takes a lot of energy to be part of that particular study.

But anyway, others have come in.

And so, yeah, we've been running this for some time.

And the idea is to see what a healthy profile looks like.

How does it change over time, which we interpret as aging?

You know, what happens when people first get ill?

And we are very enamored by these technologies.

In fact, we invented some of them.

Our lab did for these omics technologies like something called RNA-seq where we can measure all your transcripts and we have ways of following all your proteins with protein chips and things like that.

So our lab did invent a lot of these.

They're called omics technologies.

So it's ways of collecting big data from, again, your blood, your urine, and even your microbiome.

And so we basically sequenced people's genome, made all these measurements, and followed them over time.

I was going to say we're also curious whether we could use some of these technologies like genome sequencing and, you know –

This method for measuring transcripts, aren't you seeking things for better, you know, maybe managing people's health.